Tommasi M, Castelletti D, Pasti M, Fracasso G, Lorenzetti I, Sartoris S, Pera C, Ferrara G B, Tridente G, Colombatti M
Section of Immunology, Department of Pathology, University of Verona, Italy.
Clin Exp Immunol. 2001 Sep;125(3):391-400. doi: 10.1046/j.1365-2249.2001.01525.x.
The identification of ricin toxin A-chain (RTA) epitopes and the molecular context in which they are recognized will allow strategies to be devised that prevent/suppress an anti-RTA immune response in patients treated with RTA-based immunotoxins. RTA-specific human T-cell lines and T-cell clones were produced by in vitro priming of PBMC. The T-cell clones used a limited set of Vbeta chains (Vbeta1, Vbeta2 and Vbeta8) to recognize RTA epitopes. The use of RTA deletion mutants demonstrated that T-cell lines and T-cell clones from three out of four donors responded to RTA epitopes within the domain D124-Q223, whereas one donor recognized the region I1-D124. The response to RTA peptides of T-cell lines and T-cell clones from two donors allowed the identification of immunogenic segments (D124-G140 and L161-T190) recognized in the context of different HLA-DRB1 alleles (HLA-DRB10801, and HLA-DRB111011 and B103011, respectively). The response to L161-T190 was investigated in greater detail. We found that the HLA-DRB103011 allele presents a minimal epitope represented by the sequence I175-Y183 of RTA, whereas the HLA-DRB111011 allele presents the minimal epitope M174-I184. RTA peptides and an I175A RTA point mutant allowed us to identify I175 as a crucial residue for the epitope(s) recognized by the two HLA-DRB1 alleles. Failure of T-cell clones to recognize ribosome inactivating proteins (RIPs) showing sequences similar but not identical to RTA further confirmed the role of I175 as a key residue for the epitope recognized in the context of HLA-DRB111011/03011 alleles.
鉴定蓖麻毒素A链(RTA)表位及其被识别的分子环境,将有助于设计出相关策略,以预防/抑制接受基于RTA的免疫毒素治疗的患者产生抗RTA免疫反应。通过体外刺激外周血单核细胞(PBMC)产生了RTA特异性人T细胞系和T细胞克隆。这些T细胞克隆使用有限的一组Vβ链(Vβ1、Vβ2和Vβ8)来识别RTA表位。使用RTA缺失突变体表明,来自四个供体中的三个供体的T细胞系和T细胞克隆对结构域D124-Q223内的RTA表位有反应,而一个供体识别区域I1-D124。来自两个供体的T细胞系和T细胞克隆对RTA肽的反应,使得能够鉴定在不同HLA-DRB1等位基因(分别为HLA-DRB10801、HLA-DRB111011和B103011)背景下被识别的免疫原性片段(D124-G140和L161-T190)。对L161-T190的反应进行了更详细的研究。我们发现,HLA-DRB103011等位基因呈现出一个由RTA的I175-Y183序列代表的最小表位,而HLA-DRB111011等位基因呈现出最小表位M174-I184。RTA肽和一个I175A RTA点突变体使我们能够确定I175是这两个HLA-DRB1等位基因识别的表位的关键残基。T细胞克隆无法识别显示与RTA序列相似但不完全相同的核糖体失活蛋白(RIP),这进一步证实了I175作为在HLA-DRB111011/03011等位基因背景下被识别的表位的关键残基的作用。